Background: Dietary magnesium could modify the major stroke risk factors, high blood 1 pressure (BP) and cholesterol, but has been understudied in both sexes in a single population. 2
INTRODUCTION 18
Stroke accounts for more than 5.5 million deaths annually and by 2020 predictions estimate 19 that the global burden of stroke will account for 61 million disability-adjusted life years (1) . 20 Elevated BP 1 is a significant modifiable risk factor for stroke with an approximate fourfold 21 increase in stroke risk in hypertensive individuals compared with the normotensive population 22 (2) . Although established evidence indicates that elevated BP, hypertension and circulating 23 cholesterol can be modified by dietary intake including: salt, alcohol, saturated fat and 24 cholesterol (2) other dietary components, including magnesium, which is abundantly available 25 in nuts, green leafy vegetables and whole grains, have been less extensively studied. 26 Magnesium has a number of metabolic roles in the body and may influence BP and blood lipids 27 through different mechanisms (3, 4) . Magnesium may serve as a natural calcium channel 28 blocker, exhibit beneficial effects on platelet coagulation, have a potential role in vasodilation 29 and has been associated with reduced coronary artery calcification (4, 5) . Other proposed 30 mechanisms include increased peroxidation of lipoproteins with subsequent acceleration of 31 atherosclerotic plaque formation and low magnesium may facilitate an increase in 32 inflammation which is associated with negative changes in lipid profile (3, 4) . Higher 33 magnesium intake has been associated with lower risk of Type II diabetes (6) , metabolic 34 syndrome (7) and cardiovascular disease (CVD) (8) . 35 Two recent meta-analyses have investigated the effects of dietary magnesium on stroke risk 36 and CVD risk respectively (8, 9) showing inconsistent findings. The reason for these 37 1 Abbreviations 7DD -seven day diet diary, BMI -body mass index, BP -blood pressure, CVD -cardiovascular disease, DBP -diastolic blood pressure, DINER -Data Into Nutrients for Epidemiological Research, EPIC-NorfolkEuropean Prospective Investigation into Cancer-Norfolk, FFQ -food frequency questionnaire, HDL -high density lipoprotein, HLQ -Health and Lifestyle Questionnaire, LDL -low density lipoprotein, MI -myocardial infarction, SBP -systolic blood press, TC -total cholesterol, WHR -waist-hip ratio inconsistencies may be due to estimation of magnesium intakes from less precise methods of 38 recording diet such as Food Frequency Questionnaires (FFQ) and 24 hour recalls. However, it 39 has been increasingly suggested that the detailed 7DD represents dietary intakes more precisely 40 (10) . 41 Therefore, the purpose of this study was to determine whether dietary magnesium intake, 42 estimated using a 7DD, was associated with BP, lipid profile and stroke risk in an adult general 43 population of 4,443 (representative of larger cohort 25,639) men and women. 44
SUBJECTS AND METHODS 45

Study population 46
The present study population is comprised of a randomly selected representative sample 47 if they answered "no" to the question "Have you ever smoked as much as one cigarette a day 85 for as long as a year". All other participants with valid data were classified as former smokers 86 (missing data were treated as 'current'). Physical activity was assessed by the use of a short 87 physical activity questionnaire which assessed typical activity over the previous 12 months. 88 Physical activity status took account of both work and leisure related activities and participants 89
were ranked into one of four categories (inactive, moderately inactive, moderately active and 90 active) (10) . The repeatability and validity of these was confirmed against heart-rate 91 monitoring (12) . 92
Education level was determined from the HLQ and was defined at the highest qualification 93 obtained at that time. Participants were ranked into one of four categories: 'degree or 94 equivalent', A-level or equivalent', 'O-level or equivalent', and less than O-level or 95 equivalent'. 96
Previous Medical History 97
The presence of a number of existing underlying medical conditions was ascertained using the 98 HLQ. Conditions of interest included; stroke, cancer, myocardial infarction and diabetes 99 amongst others. In conjunction with this, participants were requested to detail any medication 100 that they were currently taking. 101
Dietary Assessment Method 102
Participants were requested to record all food and drink items consumed within the 7 day period 103 in a food record diary. Included in each food diary were colour photographs of 17 foods, each 104 with three incremental portion sizes. Participants were requested to indicate which photograph 105 best represented their portion size for each of the items. They were also asked to record the 106 weight of food items or use household measures to describe the portion size. The use of dietary 107 supplements was also recorded within the diary, and data was input into a specifically designed 108 program ViMiS (vitamin and mineral supplements) (13) . The 7-day diary was chosen after 109 validation studies showed its reproducibility and relative validity and indicated that the diet 110 diaries provide a more accurate representation of dietary intakes, over FFQs (10, 14) . These 111 studies indicate that FFQs overestimate dietary intakes of a number of food groups including 112 fruit and vegetables, milk and cheese which influence the magnesium intake estimates. 113
A specific program, DINER (Data Into Nutrients for Epidemiological Research), was 114 developed for entry of dietary information from the 7-day food diaries (15) . DINER allows the 115 detailed information provided in diet diaries to be translated into structured data files for 116 nutritional analysis. The program is more flexible than other software which enables the detail 117 of the diary, including cooking method, type of fat used and commercial brand names of 118 products, to be retained (16). Due to the classification structure used to code food items DINER 119 is also able to adapt to changes in food items available on the consumer market (15) . The input 120 of items from the food diaries requires a high level of detail, which reduces the risk of bias 121 between coders, and analysis of consistency has echoed this (15) . Nutritionists, trained to use 122 the DINERMO program, checked the entered data after which nutrient quantities were 123 calculated and checked for a final time (17) . 124
The ratio of calcium to magnesium intake was calculated by dividing dietary calcium intake 125 by dietary magnesium intake. 126
Statistical Methods 127
All statistical analyses were conducted using the statistical software intake in order to demonstrate the effect of magnesium intake independent of total caloric 142 intake, as well as previous incident myocardial infarction (MI) or diabetes at baseline, family 143 history of stroke and MI (BP model only). Alcohol intake, dietary potassium and sodium were 144 included due to their associations with BP (2) and total fat (TC model only). The use of calcium 145 supplements and the ratio of calcium to magnesium intake were included; these two ions 146 antagonise each other, may compete during intestinal absorption and the Ca:Mg ratio may be 147 important for total mortality and coronary heart disease (20) . 148
For stroke risk, model 1 comprised age, BMI, smoking, PA, education and alcohol intake. A modified Prentice-weighted Cox regression analysis, for case-cohort studies, was used to 154 calculate hazard ratios with 95% CIs for the risk of incident of stroke in association with dietary 155 magnesium intake (21) . This modified method accounts for the potential overlap of participants 156 with incident stroke and also randomly present in the representative sub-cohort. Analyses were 157
conducted by sex-stratified data derived categories of magnesium intake with the lowest 10% 158 of intakes (<214mg/d and <180mg/d for men and women), forming the reference category, and 159 subsequent 30% groups of magnesium intake. This approach was taken as we hypothesised 160 that the lowest risk of incident stroke would be in those with the highest dietary magnesium 161
intakes. 162
Sensitivity analysis was conducted excluding those taking antihypertensive and statin 163 medication respectively. 164
Total energy was not included as a covariate in cox regression analysis. This was for a number 165 of reasons, including that in the cox regression we adjusted for classical risk factors for stroke 166 and have previously adjusted for total energy in early BP analyses, which indicated that dietary 167 magnesium intake has an effect on BP independently of total energy, specifically for men, and 168 BP was included in cox regression analyses. Additionally with the inclusion of total energy 169 there is potential for collinearity, as a number of covariates included in the model such as BMI, 170 alcohol intake and physical activity are highly correlated with total energy intake. There is also 171 the potential for over adjustment, and for these reasons we chose not to include total energy in 172 the cox regression models. 173
RESULTS 174
In the 4,443 participants included in these analyses 45.0% were male, with an age range of 39 In men but not women, there were inverse associations between dietary magnesium intake and 193 SBP and DBP that remained significant after analysis that accounted for age, dietary sodium 194 intake and use of aspirin or antihypertensive medication ( Table 2 ). There were differences of 195 -7 mmHg and -3.8 mmHg between Quintile-1 and Quintile-5 in SBP and DBP (P≤0.01 and 196 P=0.01 respectively). In women there were no significant associations between dietary 197 magnesium intake and SBP or DBP (Table 2) . 198
Significant inverse associations between dietary magnesium intakes and TC were identified for 199 both genders (P=0.02 in men and P=0.04 in women) after adjustment for anthropometric and 200 lifestyle factors (Table 2) . However, these associations were attenuated with the addition of 201 dietary factors; alcohol intake, total fat intake, ratio of Ca:Mg, total energy and calcium 202 supplement intake to the multivariate model but remained significant (P=0.02 in men and 203 P=0.04 in women) ( Table 2) . 204
Sensitivity analysis excluding those on antihypertensive medication (n=1583 men and 1927 205 women) or statin medication (n=1973 men and 2400 women) provided similar results. 206
Stroke risk showed a non-significant inverse trend across quintiles of dietary magnesium 207 intakes in men and women after adjustment ( Table 3) . In further analyses examining 208 magnesium intake by categories there was a significant trend across categories in men. In those 209 in the highest 30 th percentile of dietary magnesium intake ( Table 4) , in men, but not in women 210 (Table 4) , there was a 41% relative reduction of stroke risk (HR 0.59 95% CI 0.38-0.93 211 (P=0.04)) compared to the lowest 10% of magnesium intakes. Although stroke risk was also 212 lower in women this was not significant. 213
Sensitivity analyses excluding those taking antihypertensive medication attenuated the 214 association of stroke risk in men to be non-significant and strengthened the association in 215 women to be significant and separately excluding those taking statin medication attenuated the 216 association in men to be non-significant. those with the highest and lowest intakes in 615 older Japanese men (age 63-82 years) using 232 24hr recall. Using 7d food diary data, a more robust measure of dietary intakes, in a 233 representative general population of middle and older age we identified slightly greater 234 differences in BP between extreme quintiles of magnesium intakes with a difference of -7 235 mmHg (P<0.001) and -3.8 mmHg (P<0.001) for SBP and DBP respectively. We identified 236 between quintiles differences were 250 mg/d for men, and 198mg/d for women, the equivalent 237 to approximately 2 slices of wholemeal bread with peanut butter and 9 Brazil nuts, therefore 238 achievable through dietary intakes (23) . We also noted a tendency towards lower fruit, 239 vegetable and bread and cereal intake in those with the lowest dietary magnesium intakes and 240 may be relevant for identifying individuals whom may benefit from increased intake. 241
In women a potential benefit from increased consumption of magnesium has previously been 242 reported (24) (25) (26) . Witteman et al (22) and Song et al (23) showed a reduction in relative risk 243 RR 0.77 95%CI: 12%-33% and RR 0.93, 95% CI 0.86-1.02 respectively for developing 244 hypertension in prospective studies using FFQs. Also a meta-analysis of RCTs using oral 245 magnesium supplements also reported a dose dependent effect of supplementation on blood 246 pressure (27) . This is in contrast to the current study where we did not find any significant 247 trends between magnesium intake and BP in women. This discrepancy may be due to 248 differences in the models used. For example Witteman et al (1989) (24) did not adjust for 249 lifestyle factors including physical activity levels and smoking status which are known to 250 influence BP. We further explored why we might have identified differences between genders. 251
It may be due to the fact that older age, higher BMI, and higher level of physical inactivity 252 were more prevalent in women with low magnesium intakes which may in part explain why a 253 significant effect was shown in men not women. As highlighted in the results section 254 differences were identified between those with the lowest 10% of intakes and those with higher 255 intakes, however, we took these factors into account during our analyses. It is also of note that 256 differences identified were largely the same for both men and women, although there was a 257 higher percentage of women, with the lowest 10% magnesium intakes, using antihypertensive 258 medication which may influence the findings due to modifying effect of medication on future 259 risk. In addition there was a narrower range of magnesium intakes for women (644mg/d) 260 compared with men (744mg/d) which may attenuate the results. It may also be that the cohort 261 was insufficiently powered to detect an affect in women. 262 A number of intervention trials, using oral magnesium supplements, have reported significant 263 reductions in BP ranging from 2.0 -12.0 and 2.7 -8.0 mmHg for SBP and DBP respectively 264 (28) (29) (30) (31) (32) . Although, the supplement doses were comparable with dietary intake, ranging 265 between 200 mg/d to 600 mg/d, the formulations used were inconsistent. 266
Limited studies have previously investigated associations between dietary magnesium intake 267 and TC or subfractions and two previous studies found no association with TC unlike our study 268 which found that TC was ≈4% lower in Quintile-5 compared with Quntile-1 (33) (34) (35) (36) . However, 269 a higher magnesium intake has been related to beneficial increases in high density lipoprotein 270 (HDL) concentrations (33, 35) . 271
Although several studies have previously investigated stroke risk and dietary magnesium 272 intakes, to our knowledge none have included populations of both men and women 273 simultaneously or included risk factors as well as stroke risk (26, (33) (34) (35) (37) (38) (39) (40) (41) (42) by Del Gobbo et al (8) in 313,041 participants, concluded that there was no significant 281 association between dietary magnesium intake and CVD. However, a significant inverse 282 association was identified in relation to circulating magnesium and CVD incidence potentially 283 indicating mechanisms that could also affect stroke risk. In addition Guasch-Ferré et al (44) 284 recently reported that an increase in magnesium intake was associated with a decrease in both 285 CVD mortality and total mortality in individuals at high CVD risk. Our results indicated a non-286 significant trend across quintiles of dietary magnesium intake and stroke risk in men and 287 women (Table 3) . However, when we compared men with the lowest 10% of magnesium intake 288 with the remainder of the cohort, we identified a significant inverse trend (P=0.04) across 289 groups in men only (Table 4) . This finding would suggest that it is the very lowest magnesium 290 intakes that may infer the greatest risk of stroke incidence, and the current findings suggest an 291 association between lower dietary magnesium intake and higher stroke risk. 292
Strengths and Limitations 293
The strengths of the present analyses include; the size of the cohort, the representativeness of 294 the UK general population and prospective design for the stroke analyses, which reduces the 295 susceptibility of the study to selection bias. The study design also reduces the likelihood of 296 measurement error, due to the recording of dietary intake at baseline prior to the onset of stroke. 297
Additionally robust and systematic adjustment for a number of potential confounding factors 298 allowed for the identification of dietary associations independent of known risk factors. It is 299 possible that factors not included in the model may also influence associations such as 300 medication use; proton pump inhibitors, and diuretics. The use of quantitative 7-day food 301 diaries is likely to have provided a more accurate representation of micronutrient intakes, 302 including magnesium intake, compared with FFQ and 24-hr recall methods (45) . To our 303 knowledge our study is the only one to use dietary intake values from 7-day diaries as opposed 304 to estimates from FFQs. Seven day food diaries have been shown to more accurately represent 305 dietary intakes of a number of food groups that contribute to magnesium intake, including fruit 306 and vegetables, and micronutrient intakes including potassium, carotene and vitamin C in 307 validation studies (14, 45, 46) . Despite this, dietary intakes do not account for variation in 308 bioavailability and absorption of magnesium, potentially the use of a biomarker would 309 strengthen the findings (47) and we were also unable to take into account possible contributions 310 of magnesium from drinking water (48). Furthermore in the same population we were able to 311 examine the complex relationship between magnesium intake, BP and cholesterol and stroke 312 risk taking into account potential relevant risk specific confounders. 313 Selection bias may be possible although the whole EPIC-Norfolk cohort was representative of 314 the UK population, with comparable cohort characteristics, and the sub-cohort for these 315 analyses was representative of the EPIC-Norfolk cohort. Furthermore, truncation of the sample 316 distribution due to potential healthy responder bias would likely only attenuate the observed 317 associations and therefore associations may actually be stronger than are presented. It should 318 also be noted that, as with other cross-sectional and observational longitudinal studies, it is not 319 possible to infer causation from these findings. However, the prospective relationship observed 320 with dietary magnesium intake and stroke risk reduces the likelihood of reverse causality. 321
Furthermore the associations were in agreement with the existing literature. Residual 322 confounding is possible but, the likelihood is reduced due to previous validation of dietary 323 methods and results of the EPIC-Norfolk cohort (46, 49) . 324
Summary 325
To our knowledge this is the first study to investigate the association of dietary magnesium 326 with BP, TC and stroke risk in a UK general population of both genders. The results suggest 327 that increased dietary magnesium could positively impact on BP and stroke risk in men and 328 total cholesterol levels in both genders. Our findings suggest that men with the lowest 329 magnesium intakes are at the greatest risk of stroke, lower magnesium intake was also 330 associated with higher blood pressure. Therefore a higher dietary magnesium intake may be 331 beneficial for prevention of stroke in men and warrants further investigation. 332
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